CardioKinetix is a medical device company offering the Parachutem, a catheter-based treatment for heart failure.
The Company, based in Menlo Park, has developed a novel transcatheter implant called the PARACHUTETM Ventricular Partitioning Device (PARACHUTETM). The PARACHUTETM intends to treat heart failure resulting from a heart attack or myocardial infarction in millions of patients worldwide by improving overall cardiac function.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 1, 2013 | Series E | $23M | 1 | — | — | Detail |
Jul 15, 2008 | Series C | $14.50M | 1 | Cutlass Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Cutlass Capital | Yes | Series C |
H&Q Healthcare Investors | — | Series E |